A PERMANENT solution to the import impasse on children’s epilepsy cannabis medication has emerged with the Dutch manufacturer set to
Pierre Van Weperen of Grow Pharma on the post-Brexit issue surrounding the import of epilepsy cannabis medicines into the UK.
Prof Mike Barnes, one of the UK’s leading cannabis clinicians responds to suggestions that the medicines for UK children with
The Advisory Council for the Misuse of Drugs’ recent report on cannabis medicines is a missed opportunity, says Pierre Van
NEW Government figures show a 900% increase in the number of cannabis medicines notified for import demonstrating the private sector’s
PATIENTS currently frozen out by an under-performing National Health Service are being offered access to cannabis medicine through a new
UK MEDICAL cannabis distributor Grow Pharma has boosted its patient product range by 20% after striking a new deal with
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
